A patient survey collaboration between Care by Design and Project CBD demonstrated that cannabis appears to be a powerful pain management tool with few negative side effects. The analysis also learned that an important decrease in opiate usage among elderly patients while taking medical cannabis.
Pain affects one’s mood, memory, relationships, and overall standard of living. Constant aches and discomfort can cause frustration, depression, anxiety, anger, social isolation, poor sleep, and related health problems. Pain is an issue. A large problem. And it gets worse as we grow older: Fifty percent of older adults who live by themselves and 75-85 percent in the elderly in care facilities reportedly suffer from chronic pain. With a growing number of people turning to marijuana for relief, this survey sought to respond to several questions: How satisfied are patients with cannabis being an analgesic? How
does medical marijuana compare to other pain management approaches, specifically, opiates? Just how do the most typical pain management therapies compare when it comes to their influence on standard of living? Eight hundred people responded for the survey over a six-week period. Most were between 50 and 70 years of age. Over 80 percent reported they were suffering from chronic pain; near half reported experiencing acute pain; about 40 % reported suffering from both. Typically, respondents had tried four different treatment methods for their pain. One out of four respondents had tried six or more treatment modalities.
Cannabis, opiates, exercise/physical rehabilitation and NSAIDs all provided noticeable relief of pain in over fifty percent of patients. Cannabis was the only real therapeutic means for which there was no reports of worsening pain. On the other hand, surgery, exercise, and nerve blockers benefited some but resulted in increased pain in a significant minority of survey participants. Cannabis and workout/physiotherapy were reported to be the most effective therapies for improving quality of life measurements. Over one half of patients using these treatment approaches reported improvements in functional ability, mood,
as well as.
A striking quantity of patients (around half) reported that opiates experienced a negative impact on overall wellbeing, and led to worsening mood, energy, functional ability and sleep.Over one half of respondents reported that they had used both cannabis and opiates for pain management. Of great interest was the impact of cannabis therapy on opiate usage: Ninety-one percent of the subgroup reported which they used fewer or no opiates after beginning cannabis therapy. Sixty-three percent said that they went off opiates altogether.
Pain affects one’s mood, memory, relationships, and overall total well being. Chronic pain can cause frustration, depression, anger, social isolation, anxiety, poor sleep, and other health hazards. 50 percent of older adults who live on their own and 75-85 percent from the elderly in care facilities reportedly suffer from chronic pain.
This survey-a collaboration between Care By Design and Project CBD-sought to answer several questions: How satisfied are patients with cannabis as being an analgesic? How does medical marijuana can compare to other pain management approaches, particularly, opiates? How do the most common pain management therapies compare in terms of their impact on standard of living?
Eight hundred people, most between 50 to 70 years of age, responded to the survey. Over 80 % reported they were struggling with chronic pain; near to half reported suffering from acute pain.
A significant reduction in opiate usage among elderly patients on cannabis therapy was the study’s most notable finding. Over 50 % of respondents reported they had used both cannabis and opiates for pain management. Of this subgroup, 91 percent said they used fewer or no opiates after beginning cannabis therapy. Sixty-three percent stated that they went off opiates altogether.
Other Key Findings: A striking quantity of patients (around half) reported that opiates had a negative influence on overall wellbeing, and resulted in worsening mood, energy, functional ability and sleep.
Cannabis was the sole therapeutic approach for which there have been no reports of worsening pain. In contrast, surgery, exercise, and nerve blockers benefited some but resulted in increased pain in a significant minority of survey participants.
There have been no significant differences in outcomes for patients using plant-derived high THC products compared to whole plant CBD-rich products; both varieties of cannabis were found to become highly effective in managing pain. The most common approach to cannabis administration was vaporization, which can be generally a secure vbgzom mode of administration-barring additives and thinning agents that may be found in inferior vaping products.
Based on this patient survey, cannabis therapy appears to be an effective pain management tool with few negative negative effects. Patient-reported outcomes of cannabis’ efficacy along with its low side-effect profile advise that it should be regarded as an initial-line remedy for pain and as an adjunct treatment to opiates as opposed to as being a medication of last resort.